TMO

Thermo Fisher Scientific Inc.

Price

$527.71

return (12m)

p/e

29.07

p/bv

3.82

DIVIDEND YIELD

0.34%

TMO price

Thermo Fisher Scientific

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TMO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals TMO

Valuation

P/E

29.07

Sector -2.34

Industry 11.10

P/BV

3.82

Sector 2.17

Industry 3.33

P/Revenue (PSR)

4.41

Sector 2.00

Industry 1.71

EV/EBITDA

83.54

Sector -23.69

Industry -398.52

EV/EBIT

112.98

Sector -36.60

Industry -80.73

P/EBITDA

17.01

Sector -0.10

Industry 8.30

P/EBIT

22.39

Sector -2.08

Industry 5.69

P/Total Assets

1.76

Sector 1.18

Industry 1.57

P/Net Current Assets

-5.12

Sector -10.91

Industry -3.38

P/Working Capital

25.87

Sector 0.09

Industry 10.51

EPS

18.41

Sector -0.93

Industry 1.10

BVPS

139.95

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

40.78%

Sector 44.28%

Industry 29.23%

EBITDA Margin

25.66%

Sector -291.45%

Industry 4.29%

EBIT Margin

18.97%

Sector -195.44%

Industry 1.44%

Operating Margin

18.16%

Sector -25.72%

Industry 2.16%

Net Profit Margins

15.15%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.10

Sector 0.12

Industry 0.27

Profitability

ROE

13.15%

Sector -34.71%

Industry 6.97%

ROA

6.05%

Sector -28.76%

Industry 2.97%

ROIC

7.62%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.34%

Sector -

Industry 0.01%

Payout

9.88%

Sector -

Industry 0.54%

Debt

Current Ratio

1.53

Sector 1.87

Industry 1.51

Net Debt / EBITDA

13.04

Sector -2.18

Industry -1.68

Net Debt / EBIT

17.63

Sector -0.74

Industry -7.00

Net Debt / Equity

0.71

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.77

Sector -0.64

Industry 0.35

Equity/Assets

0.46

Sector 0.43

Industry 0.46

Liabilities/Assets

0.54

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

2.88%

Sector -

Industry -

5Y Earnings CAGR

-2.38%

Sector -

Industry -

FAIR VALUE OF Thermo Fisher Scientific ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$527.71

Fair Value

$240.77

Upside Return potential.

-54.37%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TMO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TMO Thermo Fisher Scientific Inc.	$527.71	20.99%	0.34%	29.07	3.82	13.15%	15.15%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TMO Historical Dividends

current DY: 0.34%

5-year average DY: 0.24%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/13/2026	04/15/2026	0.47000000
Dividends	12/15/2025	01/15/2026	0.43000000
Dividends	09/15/2025	10/15/2025	0.43000000
Dividends	06/13/2025	07/15/2025	0.43000000
Dividends	03/14/2025	04/15/2025	0.43000000
Dividends	12/13/2024	01/15/2025	0.39000000
Dividends	09/13/2024	10/15/2024	0.39000000
Dividends	06/14/2024	07/15/2024	0.39000000
Dividends	03/15/2024	04/15/2024	0.39000000
Dividends	12/15/2023	01/16/2024	0.35000000
Dividends	09/15/2023	10/13/2023	0.35000000
Dividends	06/15/2023	07/14/2023	0.35000000
Dividends	03/15/2023	04/14/2023	0.35000000
Dividends	12/15/2022	01/16/2023	0.30000000
Dividends	09/15/2022	10/14/2022	0.30000000
Dividends	06/15/2022	07/15/2022	0.30000000
Dividends	03/16/2022	04/14/2022	0.30000000
Dividends	12/15/2021	01/14/2022	0.26000000
Dividends	09/15/2021	10/15/2021	0.26000000
Dividends	06/15/2021	07/15/2021	0.26000000
Dividends	03/16/2021	04/16/2021	0.26000000
Dividends	12/15/2020	01/15/2021	0.22000000
Dividends	09/15/2020	10/15/2020	0.22000000
Dividends	06/15/2020	07/15/2020	0.22000000
Dividends	03/16/2020	04/16/2020	0.22000000
Dividends	12/17/2019	01/15/2020	0.19000000
Dividends	09/17/2019	10/15/2019	0.19000000
Dividends	06/14/2019	07/16/2019	0.19000000
Dividends	03/15/2019	04/16/2019	0.19000000
Dividends	12/17/2018	01/15/2019	0.17000000
Dividends	09/17/2018	10/15/2018	0.17000000
Dividends	06/15/2018	07/16/2018	0.17000000
Dividends	03/15/2018	04/16/2018	0.17000000
Dividends	12/15/2017	01/15/2018	0.15000000
Dividends	09/15/2017	10/16/2017	0.15000000
Dividends	06/15/2017	07/17/2017	0.15000000
Dividends	03/15/2017	04/17/2017	0.15000000
Dividends	12/15/2016	01/16/2017	0.15000000
Dividends	09/15/2016	10/17/2016	0.15000000
Dividends	06/15/2016	07/15/2016	0.15000000
Dividends	03/15/2016	04/15/2016	0.15000000
Dividends	12/15/2015	01/15/2016	0.15000000
Dividends	09/15/2015	10/15/2015	0.15000000
Dividends	06/15/2015	07/15/2015	0.15000000
Dividends	03/16/2015	04/15/2015	0.15000000
Dividends	12/15/2014	01/15/2015	0.15000000
Dividends	09/15/2014	10/15/2014	0.15000000
Dividends	06/16/2014	07/15/2014	0.15000000
Dividends	03/17/2014	04/15/2014	0.15000000
Dividends	12/16/2013	01/15/2014	0.15000000
Dividends	09/16/2013	10/15/2013	0.15000000
Dividends	06/17/2013	07/15/2013	0.15000000
Dividends	03/15/2013	04/15/2013	0.15000000
Dividends	12/17/2012	01/15/2013	0.15000000
Dividends	09/17/2012	10/15/2012	0.13000000
Dividends	06/15/2012	07/16/2012	0.13000000
Dividends	03/15/2012	04/16/2012	0.13000000
Dividends	01/29/1996	01/25/1996	0.005800

ABOUT Thermo Fisher Scientific

Thermo Fisher Scientific Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

70 years

Founded: 1956

1980

Time since IPO - 46 years

80.000

Employees

Thermo Fisher Scientific Inc. (States of America) is listed on the NYSE and has a market capitalization of $199.09 billion, with shareholders equity totaling $52.06 billion.

The company employs approximately 80.000 people and operates in the Saúde sector, within the Ferramentas e Serviços de Ciências da Vida industry.

Over the past 12 months, Thermo Fisher Scientific Inc. reported $45.20 billion in revenue, generating net income of $6.85 billion.

Key financial metrics include a P/E ratio of 29.07, a price-to-book (P/B) ratio of 3.82, and a trailing twelve-month dividend yield of 0.34%.

The company trades under the ticker TMO.

Market cap

$199.09 billion

Net worth

$52.06 billion

$52,061,000,000.00

Assets

$113.28 billion

$113,281,000,000.00

Total Shares Outstanding

372.00 million

372,000,000

Average Daily Trading Volume

$2.34 million

$2,337,930.04

Sector

Saúde

Industry

Ferramentas e Serviços de Ciências da Vida

TMO

revenue by Business Segment Thermo Fisher Scientific

TMO revenue and profits

Financial Results TMO

DRAG THE FRAME TO SEE MORE DATA

TMO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56